There is currently no drug for treating non-alcoholic fatty liver disease, which affects many people with type 2 diabetes and which can result in other serious liver diseases. A study led by researchers from Karolinska Institutet ...
Feb 3, 2023
0
82
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers ...
Jan 30, 2023
0
59
The COVID-19 pandemic has been perceived in the national media as a largely partisan issue in the United States, with Democrats being portrayed as more concerned about the severity of the pandemic than Republicans. However, ...
Jan 11, 2023
0
2
Do you think that creativity is an innate gift? Think again.
Jan 9, 2023
0
4
Artificial intelligence (AI) is currently unable to pass one of the qualifying radiology examinations, suggesting that this promising technology is not yet ready to replace doctors, finds a study in the Christmas issue of ...
Dec 21, 2022
0
170
A comprehensive analysis of more than 100,000 colorectal cancer (CRC) cases, led by researchers at the Fred Hutchinson Cancer Center in Seattle and 200 scientific collaborators worldwide, has identified more than 100 new ...
Dec 20, 2022
0
58
Uganda on Thursday received its first shipment of trial vaccines against a strain of Ebola that has claimed dozens of lives, amid cautious optimism the outbreak could soon be over.
Dec 8, 2022
0
6
In 2021, a group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate ...
Dec 1, 2022
0
31
For decades, researchers have been working on "male birth control"—and studies show there is a demand. While concerns about side effects and efficacy have kept such options from the marketplace, efforts are moving forward, ...
Nov 30, 2022
0
0
Moderna announced Monday that its updated booster shot triggers strong antibody responses against three omicron subvariants.
Nov 15, 2022
0
4
